 | • レポートコード：QYR2104Z4283 • 出版社/出版日：QYResearch / 2021年4月15日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、眼科用医薬品＆デバイスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（デバイス、医薬品）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・眼科用医薬品＆デバイスの市場動向 ・企業の競争状況、市場シェア ・眼科用医薬品＆デバイスの種類別市場規模（デバイス、医薬品） ・眼科用医薬品＆デバイスの用途別市場規模（病院、診療所、その他） ・眼科用医薬品＆デバイスの北米市場規模2016-2027（アメリカ、カナダ） ・眼科用医薬品＆デバイスのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・眼科用医薬品＆デバイスのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・眼科用医薬品＆デバイスの中南米市場規模2016-2027（メキシコ、ブラジル） ・眼科用医薬品＆デバイスの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck (US)、Pfizer (US)、Roche Holdings (Switzerland)、Santen Pharmaceutical(Japan)、Alcon (Switzerland)、Bausch & Lomb (US)、Carl Zeiss Meditec (Germany)、Essilor International S.A. (France)、Johnson & Johnson (US)、Nidek(Japan)、Topcon Corporation (Japan)） ・結論 |
Ophthalmology is a branch of medicine that deals with the anatomy, physiology, and diseases of the eye.
Market Analysis and Insights: Global Opthalmology Drugs and Devices Market
The global Opthalmology Drugs and Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Opthalmology Drugs and Devices market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Opthalmology Drugs and Devices market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Opthalmology Drugs and Devices market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Opthalmology Drugs and Devices market.
Global Opthalmology Drugs and Devices Scope and Market Size
Opthalmology Drugs and Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Opthalmology Drugs and Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Device
Drug
Segment by Application
Hosptial
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck (US)
Pfizer (US)
Roche Holdings (Switzerland)
Santen Pharmaceutical(Japan)
Alcon (Switzerland)
Bausch & Lomb (US)
Carl Zeiss Meditec (Germany)
Essilor International S.A. (France)
Johnson & Johnson (US)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opthalmology Drugs and Devices Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Device
1.2.3 Drug
1.3 Market by Application
1.3.1 Global Opthalmology Drugs and Devices Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hosptial
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Opthalmology Drugs and Devices Market Perspective (2016-2027)
2.2 Opthalmology Drugs and Devices Growth Trends by Regions
2.2.1 Opthalmology Drugs and Devices Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Opthalmology Drugs and Devices Historic Market Share by Regions (2016-2021)
2.2.3 Opthalmology Drugs and Devices Forecasted Market Size by Regions (2022-2027)
2.3 Opthalmology Drugs and Devices Industry Dynamic
2.3.1 Opthalmology Drugs and Devices Market Trends
2.3.2 Opthalmology Drugs and Devices Market Drivers
2.3.3 Opthalmology Drugs and Devices Market Challenges
2.3.4 Opthalmology Drugs and Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opthalmology Drugs and Devices Players by Revenue
3.1.1 Global Top Opthalmology Drugs and Devices Players by Revenue (2016-2021)
3.1.2 Global Opthalmology Drugs and Devices Revenue Market Share by Players (2016-2021)
3.2 Global Opthalmology Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Opthalmology Drugs and Devices Revenue
3.4 Global Opthalmology Drugs and Devices Market Concentration Ratio
3.4.1 Global Opthalmology Drugs and Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opthalmology Drugs and Devices Revenue in 2020
3.5 Opthalmology Drugs and Devices Key Players Head office and Area Served
3.6 Key Players Opthalmology Drugs and Devices Product Solution and Service
3.7 Date of Enter into Opthalmology Drugs and Devices Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Opthalmology Drugs and Devices Breakdown Data by Type
4.1 Global Opthalmology Drugs and Devices Historic Market Size by Type (2016-2021)
4.2 Global Opthalmology Drugs and Devices Forecasted Market Size by Type (2022-2027)
5 Opthalmology Drugs and Devices Breakdown Data by Application
5.1 Global Opthalmology Drugs and Devices Historic Market Size by Application (2016-2021)
5.2 Global Opthalmology Drugs and Devices Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Opthalmology Drugs and Devices Market Size (2016-2027)
6.2 North America Opthalmology Drugs and Devices Market Size by Type
6.2.1 North America Opthalmology Drugs and Devices Market Size by Type (2016-2021)
6.2.2 North America Opthalmology Drugs and Devices Market Size by Type (2022-2027)
6.2.3 North America Opthalmology Drugs and Devices Market Size by Type (2016-2027)
6.3 North America Opthalmology Drugs and Devices Market Size by Application
6.3.1 North America Opthalmology Drugs and Devices Market Size by Application (2016-2021)
6.3.2 North America Opthalmology Drugs and Devices Market Size by Application (2022-2027)
6.3.3 North America Opthalmology Drugs and Devices Market Size by Application (2016-2027)
6.4 North America Opthalmology Drugs and Devices Market Size by Country
6.4.1 North America Opthalmology Drugs and Devices Market Size by Country (2016-2021)
6.4.2 North America Opthalmology Drugs and Devices Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Opthalmology Drugs and Devices Market Size (2016-2027)
7.2 Europe Opthalmology Drugs and Devices Market Size by Type
7.2.1 Europe Opthalmology Drugs and Devices Market Size by Type (2016-2021)
7.2.2 Europe Opthalmology Drugs and Devices Market Size by Type (2022-2027)
7.2.3 Europe Opthalmology Drugs and Devices Market Size by Type (2016-2027)
7.3 Europe Opthalmology Drugs and Devices Market Size by Application
7.3.1 Europe Opthalmology Drugs and Devices Market Size by Application (2016-2021)
7.3.2 Europe Opthalmology Drugs and Devices Market Size by Application (2022-2027)
7.3.3 Europe Opthalmology Drugs and Devices Market Size by Application (2016-2027)
7.4 Europe Opthalmology Drugs and Devices Market Size by Country
7.4.1 Europe Opthalmology Drugs and Devices Market Size by Country (2016-2021)
7.4.2 Europe Opthalmology Drugs and Devices Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Opthalmology Drugs and Devices Market Size (2016-2027)
8.2 Asia-Pacific Opthalmology Drugs and Devices Market Size by Type
8.2.1 Asia-Pacific Opthalmology Drugs and Devices Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Opthalmology Drugs and Devices Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Opthalmology Drugs and Devices Market Size by Type (2016-2027)
8.3 Asia-Pacific Opthalmology Drugs and Devices Market Size by Application
8.3.1 Asia-Pacific Opthalmology Drugs and Devices Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Opthalmology Drugs and Devices Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Opthalmology Drugs and Devices Market Size by Application (2016-2027)
8.4 Asia-Pacific Opthalmology Drugs and Devices Market Size by Region
8.4.1 Asia-Pacific Opthalmology Drugs and Devices Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Opthalmology Drugs and Devices Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Opthalmology Drugs and Devices Market Size (2016-2027)
9.2 Latin America Opthalmology Drugs and Devices Market Size by Type
9.2.1 Latin America Opthalmology Drugs and Devices Market Size by Type (2016-2021)
9.2.2 Latin America Opthalmology Drugs and Devices Market Size by Type (2022-2027)
9.2.3 Latin America Opthalmology Drugs and Devices Market Size by Type (2016-2027)
9.3 Latin America Opthalmology Drugs and Devices Market Size by Application
9.3.1 Latin America Opthalmology Drugs and Devices Market Size by Application (2016-2021)
9.3.2 Latin America Opthalmology Drugs and Devices Market Size by Application (2022-2027)
9.3.3 Latin America Opthalmology Drugs and Devices Market Size by Application (2016-2027)
9.4 Latin America Opthalmology Drugs and Devices Market Size by Country
9.4.1 Latin America Opthalmology Drugs and Devices Market Size by Country (2016-2021)
9.4.2 Latin America Opthalmology Drugs and Devices Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opthalmology Drugs and Devices Market Size (2016-2027)
10.2 Middle East & Africa Opthalmology Drugs and Devices Market Size by Type
10.2.1 Middle East & Africa Opthalmology Drugs and Devices Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Opthalmology Drugs and Devices Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Opthalmology Drugs and Devices Market Size by Type (2016-2027)
10.3 Middle East & Africa Opthalmology Drugs and Devices Market Size by Application
10.3.1 Middle East & Africa Opthalmology Drugs and Devices Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Opthalmology Drugs and Devices Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Opthalmology Drugs and Devices Market Size by Application (2016-2027)
10.4 Middle East & Africa Opthalmology Drugs and Devices Market Size by Country
10.4.1 Middle East & Africa Opthalmology Drugs and Devices Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Opthalmology Drugs and Devices Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck (US)
11.1.1 Merck (US) Company Details
11.1.2 Merck (US) Business Overview
11.1.3 Merck (US) Opthalmology Drugs and Devices Introduction
11.1.4 Merck (US) Revenue in Opthalmology Drugs and Devices Business (2016-2021)
11.1.5 Merck (US) Recent Development
11.2 Pfizer (US)
11.2.1 Pfizer (US) Company Details
11.2.2 Pfizer (US) Business Overview
11.2.3 Pfizer (US) Opthalmology Drugs and Devices Introduction
11.2.4 Pfizer (US) Revenue in Opthalmology Drugs and Devices Business (2016-2021)
11.2.5 Pfizer (US) Recent Development
11.3 Roche Holdings (Switzerland)
11.3.1 Roche Holdings (Switzerland) Company Details
11.3.2 Roche Holdings (Switzerland) Business Overview
11.3.3 Roche Holdings (Switzerland) Opthalmology Drugs and Devices Introduction
11.3.4 Roche Holdings (Switzerland) Revenue in Opthalmology Drugs and Devices Business (2016-2021)
11.3.5 Roche Holdings (Switzerland) Recent Development
11.4 Santen Pharmaceutical(Japan)
11.4.1 Santen Pharmaceutical(Japan) Company Details
11.4.2 Santen Pharmaceutical(Japan) Business Overview
11.4.3 Santen Pharmaceutical(Japan) Opthalmology Drugs and Devices Introduction
11.4.4 Santen Pharmaceutical(Japan) Revenue in Opthalmology Drugs and Devices Business (2016-2021)
11.4.5 Santen Pharmaceutical(Japan) Recent Development
11.5 Alcon (Switzerland)
11.5.1 Alcon (Switzerland) Company Details
11.5.2 Alcon (Switzerland) Business Overview
11.5.3 Alcon (Switzerland) Opthalmology Drugs and Devices Introduction
11.5.4 Alcon (Switzerland) Revenue in Opthalmology Drugs and Devices Business (2016-2021)
11.5.5 Alcon (Switzerland) Recent Development
11.6 Bausch & Lomb (US)
11.6.1 Bausch & Lomb (US) Company Details
11.6.2 Bausch & Lomb (US) Business Overview
11.6.3 Bausch & Lomb (US) Opthalmology Drugs and Devices Introduction
11.6.4 Bausch & Lomb (US) Revenue in Opthalmology Drugs and Devices Business (2016-2021)
11.6.5 Bausch & Lomb (US) Recent Development
11.7 Carl Zeiss Meditec (Germany)
11.7.1 Carl Zeiss Meditec (Germany) Company Details
11.7.2 Carl Zeiss Meditec (Germany) Business Overview
11.7.3 Carl Zeiss Meditec (Germany) Opthalmology Drugs and Devices Introduction
11.7.4 Carl Zeiss Meditec (Germany) Revenue in Opthalmology Drugs and Devices Business (2016-2021)
11.7.5 Carl Zeiss Meditec (Germany) Recent Development
11.8 Essilor International S.A. (France)
11.8.1 Essilor International S.A. (France) Company Details
11.8.2 Essilor International S.A. (France) Business Overview
11.8.3 Essilor International S.A. (France) Opthalmology Drugs and Devices Introduction
11.8.4 Essilor International S.A. (France) Revenue in Opthalmology Drugs and Devices Business (2016-2021)
11.8.5 Essilor International S.A. (France) Recent Development
11.9 Johnson & Johnson (US)
11.9.1 Johnson & Johnson (US) Company Details
11.9.2 Johnson & Johnson (US) Business Overview
11.9.3 Johnson & Johnson (US) Opthalmology Drugs and Devices Introduction
11.9.4 Johnson & Johnson (US) Revenue in Opthalmology Drugs and Devices Business (2016-2021)
11.9.5 Johnson & Johnson (US) Recent Development
11.10 Nidek(Japan)
11.10.1 Nidek(Japan) Company Details
11.10.2 Nidek(Japan) Business Overview
11.10.3 Nidek(Japan) Opthalmology Drugs and Devices Introduction
11.10.4 Nidek(Japan) Revenue in Opthalmology Drugs and Devices Business (2016-2021)
11.10.5 Nidek(Japan) Recent Development
11.11 Topcon Corporation (Japan)
11.11.1 Topcon Corporation (Japan) Company Details
11.11.2 Topcon Corporation (Japan) Business Overview
11.11.3 Topcon Corporation (Japan) Opthalmology Drugs and Devices Introduction
11.11.4 Topcon Corporation (Japan) Revenue in Opthalmology Drugs and Devices Business (2016-2021)
11.11.5 Topcon Corporation (Japan) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Opthalmology Drugs and Devices Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Device
Table 3. Key Players of Drug
Table 4. Global Opthalmology Drugs and Devices Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Opthalmology Drugs and Devices Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Opthalmology Drugs and Devices Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Opthalmology Drugs and Devices Market Share by Regions (2016-2021)
Table 8. Global Opthalmology Drugs and Devices Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Opthalmology Drugs and Devices Market Share by Regions (2022-2027)
Table 10. Opthalmology Drugs and Devices Market Trends
Table 11. Opthalmology Drugs and Devices Market Drivers
Table 12. Opthalmology Drugs and Devices Market Challenges
Table 13. Opthalmology Drugs and Devices Market Restraints
Table 14. Global Opthalmology Drugs and Devices Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Opthalmology Drugs and Devices Market Share by Players (2016-2021)
Table 16. Global Top Opthalmology Drugs and Devices Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opthalmology Drugs and Devices as of 2020)
Table 17. Ranking of Global Top Opthalmology Drugs and Devices Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Opthalmology Drugs and Devices Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Opthalmology Drugs and Devices Product Solution and Service
Table 21. Date of Enter into Opthalmology Drugs and Devices Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Opthalmology Drugs and Devices Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Opthalmology Drugs and Devices Revenue Market Share by Type (2016-2021)
Table 25. Global Opthalmology Drugs and Devices Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Opthalmology Drugs and Devices Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Opthalmology Drugs and Devices Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Opthalmology Drugs and Devices Revenue Market Share by Application (2016-2021)
Table 29. Global Opthalmology Drugs and Devices Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Opthalmology Drugs and Devices Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Opthalmology Drugs and Devices Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Opthalmology Drugs and Devices Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Opthalmology Drugs and Devices Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Opthalmology Drugs and Devices Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Opthalmology Drugs and Devices Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Opthalmology Drugs and Devices Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Opthalmology Drugs and Devices Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Opthalmology Drugs and Devices Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Opthalmology Drugs and Devices Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Opthalmology Drugs and Devices Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Opthalmology Drugs and Devices Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Opthalmology Drugs and Devices Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Opthalmology Drugs and Devices Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Opthalmology Drugs and Devices Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Opthalmology Drugs and Devices Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Opthalmology Drugs and Devices Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Opthalmology Drugs and Devices Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Opthalmology Drugs and Devices Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Opthalmology Drugs and Devices Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Opthalmology Drugs and Devices Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Opthalmology Drugs and Devices Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Opthalmology Drugs and Devices Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Opthalmology Drugs and Devices Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Opthalmology Drugs and Devices Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Opthalmology Drugs and Devices Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Opthalmology Drugs and Devices Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Opthalmology Drugs and Devices Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Opthalmology Drugs and Devices Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Opthalmology Drugs and Devices Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Opthalmology Drugs and Devices Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck (US) Company Details
Table 62. Merck (US) Business Overview
Table 63. Merck (US) Opthalmology Drugs and Devices Product
Table 64. Merck (US) Revenue in Opthalmology Drugs and Devices Business (2016-2021) & (US$ Million)
Table 65. Merck (US) Recent Development
Table 66. Pfizer (US) Company Details
Table 67. Pfizer (US) Business Overview
Table 68. Pfizer (US) Opthalmology Drugs and Devices Product
Table 69. Pfizer (US) Revenue in Opthalmology Drugs and Devices Business (2016-2021) & (US$ Million)
Table 70. Pfizer (US) Recent Development
Table 71. Roche Holdings (Switzerland) Company Details
Table 72. Roche Holdings (Switzerland) Business Overview
Table 73. Roche Holdings (Switzerland) Opthalmology Drugs and Devices Product
Table 74. Roche Holdings (Switzerland) Revenue in Opthalmology Drugs and Devices Business (2016-2021) & (US$ Million)
Table 75. Roche Holdings (Switzerland) Recent Development
Table 76. Santen Pharmaceutical(Japan) Company Details
Table 77. Santen Pharmaceutical(Japan) Business Overview
Table 78. Santen Pharmaceutical(Japan) Opthalmology Drugs and Devices Product
Table 79. Santen Pharmaceutical(Japan) Revenue in Opthalmology Drugs and Devices Business (2016-2021) & (US$ Million)
Table 80. Santen Pharmaceutical(Japan) Recent Development
Table 81. Alcon (Switzerland) Company Details
Table 82. Alcon (Switzerland) Business Overview
Table 83. Alcon (Switzerland) Opthalmology Drugs and Devices Product
Table 84. Alcon (Switzerland) Revenue in Opthalmology Drugs and Devices Business (2016-2021) & (US$ Million)
Table 85. Alcon (Switzerland) Recent Development
Table 86. Bausch & Lomb (US) Company Details
Table 87. Bausch & Lomb (US) Business Overview
Table 88. Bausch & Lomb (US) Opthalmology Drugs and Devices Product
Table 89. Bausch & Lomb (US) Revenue in Opthalmology Drugs and Devices Business (2016-2021) & (US$ Million)
Table 90. Bausch & Lomb (US) Recent Development
Table 91. Carl Zeiss Meditec (Germany) Company Details
Table 92. Carl Zeiss Meditec (Germany) Business Overview
Table 93. Carl Zeiss Meditec (Germany) Opthalmology Drugs and Devices Product
Table 94. Carl Zeiss Meditec (Germany) Revenue in Opthalmology Drugs and Devices Business (2016-2021) & (US$ Million)
Table 95. Carl Zeiss Meditec (Germany) Recent Development
Table 96. Essilor International S.A. (France) Company Details
Table 97. Essilor International S.A. (France) Business Overview
Table 98. Essilor International S.A. (France) Revenue in Opthalmology Drugs and Devices Business (2016-2021) & (US$ Million)
Table 99. Essilor International S.A. (France) Recent Development
Table 100. Johnson & Johnson (US) Company Details
Table 101. Johnson & Johnson (US) Business Overview
Table 102. Johnson & Johnson (US) Opthalmology Drugs and Devices Product
Table 103. Johnson & Johnson (US) Revenue in Opthalmology Drugs and Devices Business (2016-2021) & (US$ Million)
Table 104. Johnson & Johnson (US) Recent Development
Table 105. Nidek(Japan) Company Details
Table 106. Nidek(Japan) Business Overview
Table 107. Nidek(Japan) Opthalmology Drugs and Devices Product
Table 108. Nidek(Japan) Revenue in Opthalmology Drugs and Devices Business (2016-2021) & (US$ Million)
Table 109. Nidek(Japan) Recent Development
Table 110. Topcon Corporation (Japan) Company Details
Table 111. Topcon Corporation (Japan) Business Overview
Table 112. Topcon Corporation (Japan) Opthalmology Drugs and Devices Product
Table 113. Topcon Corporation (Japan) Revenue in Opthalmology Drugs and Devices Business (2016-2021) & (US$ Million)
Table 114. Topcon Corporation (Japan) Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opthalmology Drugs and Devices Market Share by Type: 2020 VS 2027
Figure 2. Device Features
Figure 3. Drug Features
Figure 4. Global Opthalmology Drugs and Devices Market Share by Application: 2020 VS 2027
Figure 5. Hosptial Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Opthalmology Drugs and Devices Report Years Considered
Figure 9. Global Opthalmology Drugs and Devices Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Opthalmology Drugs and Devices Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Opthalmology Drugs and Devices Market Share by Regions: 2020 VS 2027
Figure 12. Global Opthalmology Drugs and Devices Market Share by Regions (2022-2027)
Figure 13. Global Opthalmology Drugs and Devices Market Share by Players in 2020
Figure 14. Global Top Opthalmology Drugs and Devices Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opthalmology Drugs and Devices as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Opthalmology Drugs and Devices Revenue in 2020
Figure 16. Global Opthalmology Drugs and Devices Revenue Market Share by Type (2016-2021)
Figure 17. Global Opthalmology Drugs and Devices Revenue Market Share by Type (2022-2027)
Figure 18. North America Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Opthalmology Drugs and Devices Market Share by Type (2016-2027)
Figure 20. North America Opthalmology Drugs and Devices Market Share by Application (2016-2027)
Figure 21. North America Opthalmology Drugs and Devices Market Share by Country (2016-2027)
Figure 22. United States Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Opthalmology Drugs and Devices Market Share by Type (2016-2027)
Figure 26. Europe Opthalmology Drugs and Devices Market Share by Application (2016-2027)
Figure 27. Europe Opthalmology Drugs and Devices Market Share by Country (2016-2027)
Figure 28. Germany Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Opthalmology Drugs and Devices Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Opthalmology Drugs and Devices Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Opthalmology Drugs and Devices Market Share by Region (2016-2027)
Figure 38. China Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Opthalmology Drugs and Devices Market Share by Type (2016-2027)
Figure 46. Latin America Opthalmology Drugs and Devices Market Share by Application (2016-2027)
Figure 47. Latin America Opthalmology Drugs and Devices Market Share by Country (2016-2027)
Figure 48. Mexico Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Opthalmology Drugs and Devices Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Opthalmology Drugs and Devices Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Opthalmology Drugs and Devices Market Share by Country (2016-2027)
Figure 54. Turkey Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Opthalmology Drugs and Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Merck (US) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2016-2021)
Figure 58. Pfizer (US) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2016-2021)
Figure 59. Roche Holdings (Switzerland) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2016-2021)
Figure 60. Santen Pharmaceutical(Japan) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2016-2021)
Figure 61. Alcon (Switzerland) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2016-2021)
Figure 62. Bausch & Lomb (US) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2016-2021)
Figure 63. Carl Zeiss Meditec (Germany) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2016-2021)
Figure 64. Essilor International S.A. (France) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2016-2021)
Figure 65. Johnson & Johnson (US) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2016-2021)
Figure 66. Nidek(Japan) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2016-2021)
Figure 67. Topcon Corporation (Japan) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed